Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Vaccine with Aluminum Hydroxide in Healthy Elderly Adults
NCT00294099Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2006
- Primary completion
- Mar 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Inactivated Influenza A/H5N1 Vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2006; status: completed.
02
Drugs
Inactivated Influenza A/H5N1 Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00294099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294099.